As of 2024-12-12, the Relative Valuation of Kura Oncology Inc (KURA) is (58.56) USD. This relative valuation is based on P/E multiples. With the latest stock price at 10.20 USD, the upside of Kura Oncology Inc based on Relative Valuation is -674.1%.
The range of the Relative Valuation is (54.82) - (51.17) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.6x - 31.4x | 26.5x |
| Forward P/E multiples | 19.1x - 20.1x | 19.6x |
| Fair Price | (54.82) - (51.17) | (58.56) |
| Upside | -637.5% - -601.6% | -674.1% |
| Date | P/E |
| 2024-12-10 | -4.05 |
| 2024-12-09 | -4.14 |
| 2024-12-06 | -4.20 |
| 2024-12-05 | -4.22 |
| 2024-12-04 | -4.31 |
| 2024-12-03 | -4.40 |
| 2024-12-02 | -4.41 |
| 2024-11-29 | -4.35 |
| 2024-11-27 | -4.40 |
| 2024-11-26 | -4.23 |
| 2024-11-25 | -4.31 |
| 2024-11-22 | -4.25 |
| 2024-11-21 | -3.96 |
| 2024-11-20 | -6.26 |
| 2024-11-19 | -6.28 |
| 2024-11-18 | -6.31 |
| 2024-11-15 | -6.27 |
| 2024-11-14 | -6.49 |
| 2024-11-13 | -6.99 |
| 2024-11-12 | -7.31 |
| 2024-11-11 | -6.91 |
| 2024-11-08 | -6.96 |
| 2024-11-07 | -6.99 |
| 2024-11-06 | -7.02 |
| 2024-11-05 | -6.90 |
| 2024-11-04 | -7.01 |
| 2024-11-01 | -6.64 |
| 2024-10-31 | -6.58 |
| 2024-10-30 | -6.68 |
| 2024-10-29 | -6.83 |
| 2024-10-28 | -6.98 |
| 2024-10-25 | -6.89 |
| 2024-10-24 | -7.00 |
| 2024-10-23 | -6.70 |
| 2024-10-22 | -6.84 |
| 2024-10-21 | -6.97 |
| 2024-10-18 | -7.09 |
| 2024-10-17 | -7.12 |
| 2024-10-16 | -7.19 |
| 2024-10-15 | -7.17 |
| 2024-10-14 | -7.11 |
| 2024-10-11 | -7.31 |
| 2024-10-10 | -7.18 |
| 2024-10-09 | -7.21 |
| 2024-10-08 | -7.15 |
| 2024-10-07 | -7.04 |
| 2024-10-04 | -7.10 |
| 2024-10-03 | -7.16 |
| 2024-10-02 | -7.28 |
| 2024-10-01 | -7.56 |